SCHEMBL21036232

SCHEMBL21036232

CC(C)(C)OC(=O)NC1CC2CCC(C1)N2C(=O)[C@@H]1CN(Cc2ccc(-c3ccc(Cl)cc3)cc2)CCN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 3/20 0.38
MMP1 P03956 2/20 0.38
MMP9 P14780 2/20 0.38
MMP13 P45452 2/20 0.38
MMP3 P08254 1/20 0.38
MMP7 P09237 1/20 0.38
ROCK2 O75116 1/20 0.37
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MCL1 Q07820 4/20 0.35
BCL2 P10415 1/20 0.35
BCL2L1 Q07817 1/20 0.35
HTR1A P08908 2/20 0.35
HTR7 P34969 2/20 0.35
HTR5A P47898 2/20 0.35
HTR1D P28221 1/20 0.35
HTR1B P28222 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
ADRA1A P35348 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035093 1.00 CCR4 (0.38) CCR4MMP1MMP9MMP13MMP3
SCHEMBL21036186 1.00 CCR4 (0.38) CCR4MMP1MMP9MMP13MMP3
SCHEMBL21035343 0.92 CCR4 (0.42) CCR4MMP1MMP9MMP13MMP3
SCHEMBL21035072 0.92 CCR4 (0.42) CCR4MMP1MMP9MMP13MMP3
SCHEMBL21035330 0.92 CCR4 (0.42) CCR4MMP1MMP9MMP13MMP3
SCHEMBL21035131 0.88 ITGB1 (0.38) KMT2AL3MBTL1MCL1BCL2BCL2L1
SCHEMBL21035008 0.88 ITGB1 (0.38) KMT2AL3MBTL1MCL1BCL2BCL2L1
SCHEMBL21035404 0.87 MMP9 (0.36) MMP1MMP9MMP3KMT2AL3MBTL1
SCHEMBL21035094 0.87 CHEK2 (0.40) CCR4MMP1MMP9MMP13MMP3
SCHEMBL21036231 0.87 CHEK2 (0.40) CCR4MMP1MMP9MMP13MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed